Cuban Labiofam Group to Unveil New Anti Cancer Drug

Cuban Labiofam Group to Unveil New Anti Cancer Drug

Cuban Labiofam Group to Unveil New Anti Cancer Drug

Havana, Jul 21  –  Cubas Labiofam Entrepreneurial Group is carrying out researches to develop a new anti-cancer drug from the RJLB14, reported Juventud Rebelde daily on Sunday.

According to Labiofam director Jose Antonio Fraga, the product is under strict toxicology tests to then clinically tested it in human beings, after the approval by corresponding entities of absolute guarantees to use in humans.

Fraga adds that the latest results in relation to the RJLB14 have been presented by the Ministry of Health Directive Board, with a report that includes the respective tests and evidences on the pre-clinic tests.

This new drug goes through the membrane of the bad cells and kills it, which makes it diffrent from other drugs now in existance, said Fraga.

For his part, researcher Alexis Día said that this research is the result of 14 years of work, and made reference to the test carried out at European labs.

Source: Prensa Latina

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s